trending Market Intelligence /marketintelligence/en/news-insights/trending/rppho52mozvfa12iojmlxg2 content esgSubNav
In This List

AxoGen closes $132.5M common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AxoGen closes $132.5M common stock offering

AxoGen Inc. closed its public offering of common shares with net proceeds of about $132.5 million.

The company offered 3,450,000 shares at $41 apiece, and the underwriters fully exercised their overallotment option to buy 450,000 additional shares.

AxoGen intends to use the net proceeds for long-term facility and capacity expansion and general corporate purposes.

Jefferies LLC and Leerink Partners LLC acted as joint book-running managers, while William Blair & Co. LLC and JMP Securities LLC acted as co-managers for the offering.

Alachua, Fla.-based AxoGen develops and markets surgical solutions for peripheral nerve injuries.